Immunization with a Peptide Containing MHC Class I and II Epitopes Derived from the Tumor Antigen SIM2 Induces an Effective CD4 and CD8 T-Cell Response

Kissick, Haydn T.; Sanda, Martin G.; Dunn, Laura K.; Arredouani, Mohamed S.
April 2014
PLoS ONE;Apr2014, Vol. 9 Issue 4, p1
Academic Journal
Here, we sought to determine whether peptide vaccines designed harbor both class I as well as class II restricted antigenic motifs could concurrently induce CD4 and CD8 T cell activation against autologous tumor antigens. Based on our prior genome-wide interrogation of human prostate cancer tissues to identify genes over-expressed in cancer and absent in the periphery, we targeted SIM2 as a prototype autologous tumor antigen for these studies. Using humanized transgenic mice we found that the 9aa HLA-A*0201 epitope, SIM2237–245, was effective at inducing an antigen specific response against SIM2-expressing prostate cancer cell line, PC3. Immunization with a multi-epitope peptide harboring both MHC-I and MHC-II restricted epitopes induced an IFN-γ response in CD8 T cells to the HLA-A*0201-restricted SIM2237–245 epitope, and an IL-2 response by CD4 T cells to the SIM2240–254 epitope. This peptide was also effective at inducing CD8+ T-cells that responded specifically to SIM2-expressing tumor cells. Collectively, the data presented in this study suggest that a single peptide containing multiple SIM2 epitopes can be used to induce both a CD4 and CD8 T cell response, providing a peptide-based vaccine formulation for potential use in immunotherapy of various cancers.


Related Articles

  • T-Cell Receptor-Like Antibodies: Targeting the Intracellular Proteome Therapeutic Potential and Clinical Applications. Cohen, Maya; Reiter, Yoram // Antibodies (2073-4468); 

    Major histocompatibility complex (MHC) class I molecules are key in the immune response against malignant cells by shaping the T-cell repertoire and presenting peptides from endogenous antigens to CD8+ cytotoxic T cells. Because of their unique specificity, MHC-peptide complexes are a desirable...

  • CD4+ T cell lineage integrity is controlled by the histone deacetylases HDAC1 and HDAC2. Boucheron, Nicole; Tschismarov, Roland; Goeschl, Lisa; Moser, Mirjam A; Lagger, Sabine; Sakaguchi, Shinya; Winter, Mircea; Lenz, Florian; Vitko, Dijana; Breitwieser, Florian P; Müller, Lena; Hassan, Hammad; Bennett, Keiryn L; Colinge, Jacques; Schreiner, Wolfgang; Egawa, Takeshi; Taniuchi, Ichiro; Matthias, Patrick; Seiser, Christian; Ellmeier, Wilfried // Nature Immunology;May2014, Vol. 15 Issue 5, p439 

    Molecular mechanisms that maintain lineage integrity of helper T cells are largely unknown. Here we show histone deacetylases 1 and 2 (HDAC1 and HDAC2) as crucial regulators of this process. Loss of HDAC1 and HDAC2 during late T cell development led to the appearance of major histocompatibility...

  • MHC Restriction. Vohr, Hans-Werner // Encyclopedic Reference of Immunotoxicology;2005, p444 

    The entry explains major histocompatibility complex (MHC) restriction. Because of the nature of α β T cell receptor, the characteristic of T lymphocytes when they are bound to a particular allelic form of a MHC molecule, is to recognize foreign peptides. Both the CD4+ and CD8+recognize...

  • Split T Cell Tolerance against a Self/Tumor Antigen: Spontaneous CD4+ but Not CD8+ T Cell Responses against p53 in Cancer Patients and Healthy Donors. Tsuji, Takemasa; Matsuzaki, Junko; Ritter, Erika; Miliotto, Anthony; Ritter, Gerd; Odunsi, Kunle; Old, Lloyd J.; Gnjatic, Sacha // PLoS ONE;2011, Vol. 6 Issue 8, p1 

    Analyses of NY-ESO-1-specific spontaneous immune responses in cancer patients revealed that antibody and both CD4+ and CD8+ T cell responses were induced together in cancer patients. To explore whether such integrated immune responses are also spontaneously induced for other tumor antigens, we...

  • Simultaneous activation of T helper function can augment the potency of dendritic cell-based cancer immunotherapy. Teramoto, Koji; Ohshio, Yasuhiko; Fujita, Takuya; Hanaoka, Jun; Kontani, Keiichi // Journal of Cancer Research & Clinical Oncology;May2013, Vol. 139 Issue 5, p861 

    Purpose: Simultaneous activation of T helper 1 (Th1) cell function has crucial roles in induction of potent cytotoxic T lymphocyte (CTL) responses in cancer immunotherapy. Here, we investigated whether dendritic cell (DC)-based vaccines loaded with both tumor-associated antigen (TAA)-derived MHC...

  • Empowering gamma delta T cells with antitumor immunity by dendritic cell-based immunotherapy. Van Acker, Heleen H; Anguille, Sébastien; Van Tendeloo, Viggo F; Lion, Eva // OncoImmunology;Aug2015, Vol. 4 Issue 8, p00 

    Gamma delta (γδ) T cells are the all-rounders of our immune-system with their major histocompatibility complex-unrestricted cytotoxicity, capacity to secrete immunosti-mulatory cytokines and ability to promote the generation of tumor antigen-specific CD8+and CD4+T cell responses. Dendritic...

  • CD4+ T-Cell Help Is Required for Effective CD8+ T Cell-Mediated Resolution of Acute Viral Hepatitis in Mice. Trautmann, Tanja; Kozik, Jan-Hendrik; Carambia, Antonella; Richter, Kirsten; Lischke, Timo; Schwinge, Dorothee; Mittrücker, Hans-Willi; Lohse, Ansgar W.; Oxenius, Annette; Wiegard, Christiane; Herkel, Johannes // PLoS ONE;Jan2014, Vol. 9 Issue 1, p1 

    Cytotoxic CD8+ T cells are essential for the control of viral liver infections, such as those caused by HBV or HCV. It is not entirely clear whether CD4+ T-cell help is necessary for establishing anti-viral CD8+ T cell responses that successfully control liver infection. To address the role of...

  • Establishment of the reversible peptide-major histocompatibility complex (pMHC) class I Histamer technology: tool for visualization and selection of functionally active antigen-specific CD8+ T lymphocytes. Tischer, Sabine; Kaireit, Till; Figueiredo, Constança; Hiller, Oliver; Maecker-Kolhoff, Britta; Geyeregger, Renè; Immenschuh, Stephan; Blasczyk, Rainer; Eiz-Vesper, Britta // International Immunology;Sep2012, Vol. 24 Issue 9, p561 

    Multimers of soluble peptide-major histocompatibilty complex (pMHC) molecules are used in both basic and clinical immunology. They allow the specific visualization and isolation of antigen-specific T cells from ex vivo samples. Adoptive transfer of antigen-specific T cells sorted by pMHC...

  • Modulation of CD8+ T cell responses to AAV vectors with IgG-derived MHC class II epitopes. Hui, Daniel J; Basner-Tschakarjan, Etiena; Chen, Yifeng; Davidson, Robert J; Buchlis, George; Yazicioglu, Mustafa; Pien, Gary C; Finn, Jonathan D; Haurigot, Virginia; Tai, Alex; Scott, David W; Cousens, Leslie P; Zhou, Shangzhen; De Groot, Anne S; Mingozzi, Federico // Molecular Therapy;Sep2013, Vol. 21 Issue 9, p1 

    Immune responses directed against viral capsid proteins constitute a main safety concern in the use of adeno-associated virus (AAV) as gene transfer vectors in humans. Pharmacological immunosuppression has been proposed as a solution to the problem; however, the approach suffers from several...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics